Serotonin Club Meetings 2012-2016

2012-2016 年血清素俱乐部会议

基本信息

项目摘要

DESCRIPTION (provided by applicant): The Serotonin Club, founded in 1987, is an international association for biomedical scientists who are interested in research on any aspect of serotonin. An important objective of the Club is to facilitate the involvement of young investigators, comprising students, post-doctoral fellows and junior researchers (less than 3 years past their post-doctoral fellowship) in an international high-quality scientific meeting with serotonin as its central theme. Serotonin has been implicated in substance abuse, pain, cardiovascular and gastrointestinal function, neural development as well as a host of psychiatric diseases, including addiction. A diverse audience is attracted by including not only the neuroscience of serotonin, and the neurotransmitter systems on which it impinges, but also the role of serotonin in peripheral function. Thus, our goal is to bring together researchers with a common interest in serotonin such that the depth of its functions, and importantly, new discoveries, can be communicated. A new initiative of the Serotonin Club Meetings is to provide a focus and build a strong emphasis on substance abuse, as it relates to serotonin's interactions with other neurotransmitter systems, and importantly, to understand serotonin's role in the disease of addiction and how this system can be targeted for the treatment of substance abuse. A key goal of the 2012 meeting will be to foster this new initiative by inclusion of symposia directly related to substance abuse. Importantly, a major goal of the Serotonin Club is to provide a dynamic forum to help develop the careers of young investigators in the field. As such, we plan to include ten recipients of NIDA Travel Awards as featured speakers, one in each of ten programmed symposia. In addition these young investigators will i) be part of a mentoring program, ii) be able to network with senior researchers, including leaders in the field, at many occasion (e.g. poster sessions, breaks, lunches, and dinner banquet); and iii) have their work published in the conference proceedings. Selection will be based on the applicant's credentials and on the relevance of their abstract to drug abuse and related disorders. The first meeting of the Serotonin Club for which funds are sought will be held July 10-12, 2012 in Montpellier, France. The primary aim of this R13 application is to provide financial support to these young investigators to enable them to attend and participate in the 2012 Serotonin Club Meeting as well as to support future young investigators to attend subsequent meetings in 2014 and 2016.
描述(由申请人提供):1987年成立的5-羟色胺俱乐部是一家国际生物医学科学家协会,对有关5-羟色胺任何方面的研究感兴趣。俱乐部的一个重要目标是在一次国际高质量的科学会议上促进年轻调查人员,包括学生,博士后研究员和初级研究人员(少于三年后的研究金)的参与。 5-羟色胺作为中心主题。 5-羟色胺与药物滥用,疼痛,心血管和胃肠道功能有关,神经发育以及包括成瘾在内的精神疾病。不仅包括5-羟色胺的神经科学及其影响的神经递质系统,还包括5-羟色胺在外周功能中的作用,吸引了不同的受众。因此,我们的目标是将具有共同兴趣的研究人员汇集在一起​​,以便可以传达其功能的深度,重要的是,新发现。 5-羟色胺俱乐部会议的一项新举措是提供重点,并强烈重视滥用药物,因为它与5-羟色胺与其他神经递质系统的相互作用有关,并且重要的是,重要的是了解5-羟色胺在成瘾疾病中的作用以及如何针对该系统来靶向药物滥用。 2012年会议的一个关键目标是通过纳入与药物滥用直接相关的研讨会来促进这项新倡议。重要的是,5-羟色胺俱乐部的主要目标是提供一个动态的论坛,以帮助培养该领域的年轻调查员的职业。因此,我们计划将十个NIDA Travel Awards的获奖者作为特色演讲者,其中十个编程的研讨会中的每一个。此外,这些年轻的调查人员还将成为指导计划的一部分,ii)能够与包括该领域的领导者在内的高级研究人员建立联系(例如,海报会议,休息时间,休息时间,午餐和晚餐宴会); iii)将其作品发表在会议记录中。选择将基于申请人的凭证以及其摘要与药物滥用和相关疾病的相关性。寻求资金的血清素俱乐部的第一次会议将于2012年7月10日至12日在法国蒙彼利埃举行。该R13申请的主要目的是为这些年轻的调查人员提供财政支持,以使他们能够参加并参加2012年血清素俱乐部会议,并支持未来的年轻调查人员参加2014年和2016年的随后会议。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LYNETTE C DAWS其他文献

LYNETTE C DAWS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LYNETTE C DAWS', 18)}}的其他基金

Uptake2 transporters: Novel sex-dependent molecular targets to treat stimulant use disorder
Uptake2转运蛋白:治疗兴奋剂使用障碍的新型性别依赖性分子靶标
  • 批准号:
    10595444
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Organic cation transporter 3: a novel molecular target to treat amphetamine abuse
有机阳离子转运蛋白 3:治疗苯丙胺滥用的新型分子靶点
  • 批准号:
    9808668
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
Exploring a role for organic transporter 3 in the mechanism of action of drugs of abuse
探索有机转运蛋白 3 在滥用药物作用机制中的作用
  • 批准号:
    9788402
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Age-related differences in serotonin clearance: novel targets for antidepressants
血清素清除率与年龄相关的差异:抗抑郁药的新目标
  • 批准号:
    9062518
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
The dopamine transporter in eating disorders: Uncovering new therapeutic targets
饮食失调中的多巴胺转运蛋白:发现新的治疗靶点
  • 批准号:
    8771759
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
The dopamine transporter in eating disorders: Uncovering new therapeutic targets
饮食失调中的多巴胺转运蛋白:发现新的治疗靶点
  • 批准号:
    8845537
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
Organic Cation Transporters as Targets for Novel Antidepressant Drugs
有机阳离子转运蛋白作为新型抗抑郁药物的靶标
  • 批准号:
    8424968
  • 财政年份:
    2012
  • 资助金额:
    --
  • 项目类别:
Organic Cation Transporters as Targets for Novel Antidepressant Drugs
有机阳离子转运蛋白作为新型抗抑郁药物的靶标
  • 批准号:
    8262100
  • 财政年份:
    2012
  • 资助金额:
    --
  • 项目类别:
Organic Cation Transporters as Targets for Novel Antidepressant Drugs
有机阳离子转运蛋白作为新型抗抑郁药物的靶标
  • 批准号:
    8581356
  • 财政年份:
    2012
  • 资助金额:
    --
  • 项目类别:
Organic Cation Transporters as Targets for Novel Antidepressant Drugs
有机阳离子转运蛋白作为新型抗抑郁药物的靶标
  • 批准号:
    8969703
  • 财政年份:
    2012
  • 资助金额:
    --
  • 项目类别:

相似海外基金

The Role of Glycosyl Ceramides in Heart Failure and Recovery
糖基神经酰胺在心力衰竭和恢复中的作用
  • 批准号:
    10644874
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Cystathionine Gamma Lyase (CSE) and Hydrogen Sulfide Regulation of Vascular Aging
胱硫醚γ裂解酶 (CSE) 和硫化氢对血管老化的调节
  • 批准号:
    10715408
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Age-related differences in neurobiological systems supporting emotion
支持情绪的神经生物系统与年龄相关的差异
  • 批准号:
    10606216
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Oxidative Stress and Mitochondrial Dysfunction in Chemogenetic Heart Failure
化学遗传性心力衰竭中的氧化应激和线粒体功能障碍
  • 批准号:
    10643012
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Mechanisms of mitochondrial-ER communication during dietary and thermal induced stress
饮食和热应激期间线粒体-内质网通讯的机制
  • 批准号:
    10663603
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了